The Jerusalem Post
MiddleEast · 6 hrs ago
Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.
Do you trust The Jerusalem Post?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!